Inflammatory bowel disease and irritable bowel syndrome.
Kendra J KampS W MatthewsM M HeitkemperPublished in: Clinical and experimental dermatology (2020)
We read with interest the article "Feacal Calprotectin in Dermatology Practice".1 The authors discuss the potential use of feacal calprotectin in assessing for inflammatory bowel disease in dermatology practice. Yet, it is important to clarify disease definitions. The article includes the phrase irritable bowel disease, which is not used within the gastrointestinal field. Rather, IBD refers to inflammatory bowel disease in which patients have an underlying mucosal inflammation. ….